Project milestones, regulatory progress and clinical partnerships from the TEMCO project team.
TEMCO has released the formal Confidential Investment Memorandum to qualified institutional investors. The document covers the US$120M single-ticket capital ask, 25-year financial model, sovereign endorsements and clinical service framework. Full model available under NDA.
TEMCO has formalised a clinical operations partnership with Advance Medical Africa, a South Africa and Zimbabwe-based clinical services group. AMA will provide protocols, staffing pipelines and training integration for TEMCO's four Centres of Excellence.
TEMCO has been awarded the Making The Most (MTM) designation under the Botswana Economic Transformation Programme (BETP). This is the highest level of government endorsement for transformation projects in Botswana, following the PEMANDU Labs cohort process.
Three new clinical specialists have joined the TEMCO advisory team: a paediatric ICU specialist, a nuclear medicine specialist and a senior orthopaedic consultant. The expanded clinical advisory provides domain expertise across each Centre of Excellence.
TEMCO has received formal SEZA-qualifying status from the Special Economic Zone Authority. This unlocks the 5% corporate tax rate (vs the 22% standard, stepping up to 10% after year 10) and 0% customs duty on imported medical equipment, materially improving project economics.
Sailas Banda, Chairman & Project Lead, has finalised the pre-operational project team. The leadership comprises clinical, financial, operational, engineering, legal and community leads, with a senior advisory team of clinical specialists supporting each Centre of Excellence.
For ongoing updates on the TEMCO project, contact our investor relations team or sign up to receive milestone announcements.
